HOME >> MEDICINE >> NEWS
NYU'S Duster cautions against FDA approval of 'race-based' pharmaceutical

t failure than are Caucasians in the same age range. However, in the Science article, Duster responds that this age group accounts for only 6 percent of heart-failure mortality and that these statistical differences in heart failure between African Americans and Caucasians over 64 nearly disappear.

Duster bolsters his conclusions by drawing from previously published research on race and health risks. Findings published in the journal BMC Medicine, he writes, show that blacks from Africa, the Caribbean, and the United States show less disparity in hypertension rates than do whites from Europe, the United States, and Canada. The study also concluded that differences in hypertension rates between light-skinned African Americans and dark-skinned African Americans was attributed to the latter group having less access to medical and other resources in the United States.

"The ability to use genomic knowledge to deliver effective pharmaceuticals more safely to special subpopulations that have some functional genetic markers holds promise," Duster writes. "If the FDA approves BiDil, it should do so only under the condition that further research be conducted to find the markers that have the actual functional association with drug responsiveness, thus assuring that the drug be approved for everyone with those markers, regardless of their ancestry or of their ancestral informative markers."


'"/>

Contact: James Devitt
james.devitt@nyu.edu
212-998-6808
New York University
25-Feb-2005


Page: 1 2

Related medicine news :

1. Strategy effective against drug resistant tuberculosis
2. New study in Nature demonstrates protection against cell death during heart attack
3. Vaccine against childhood pneumonia shows promise
4. Mayo Clinic discovers new pathway against pancreatic cancer
5. Orthodontists must brace against back pain
6. Female sex hormones play a vital role in defense against sexually transmitted diseases
7. New European cancer figures for 2004 major efforts needed against the big four killers
8. New highly active agents against sandfly fever
9. New mosquito control strategy proves successful against dengue fever
10. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
11. Gene vaccine protects mice against development of Her2/neu breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... PurhealthRX , a leading Health and Nutrition Company, ... Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market by ... be easily incorporated into liquid products, while reducing costs to end users. , The ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) ... a collection of specialty vendors and unique items from across the nation, this holiday-themed ... and wellness services offered by the VNA. The boutique will be open Saturday, ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
Breaking Medicine Technology:
Cached News: